Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer screening on wheels: bringing early detection to High-Risk neighborhoods

NCT ID NCT06909981

Prevention Sponsor: Brigham and Women's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will bring a mobile lung cancer screening clinic to underserved neighborhoods in Boston. 125 high-risk adults (ages 50-80, current or former heavy smokers) will receive a low-dose CT scan and a video message to encourage future screening. The goal is to see if this approach is practical and acceptable, and to understand social factors that affect screening.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low-Dose Computed Tomography Scan (LDCT)
What this could lead to
If successful, this could show that bringing lung cancer screening directly to underserved communities is feasible and acceptable, potentially leading to earlier detection and better outcomes.
What could go wrong
This is a small pilot study (125 participants) focused on feasibility, not on proving that screening reduces deaths. It may not work in other communities or on a larger scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 125 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability to understand and the willingness to sign a written informed consent document prior to any study-related procedures. * Willing to undergo treatment. * Adults between the ages of 50 and 80 years. * No recent CT imaging within the last year. * Currently smokes tobacco or has quit smoking tobacco within the past 15 years. * Has a tobacco smoking history of at least 20 pack years (i.e. one pack per day for the last 20 years or equivalent). * Has never been diagnosed with lung cancer. Exclusion Criteria: * Adults/children less than 50 years, or greater than 80 years of age. * Has never smoked tobacco. * Has smoked tobacco but quit more than 15 years ago. * Has a tobacco smoking history of less than 20 pack years. * Presence of major comorbidity(ies) that could prevent treatment. * Previous diagnosis of lung cancer. * In the opinion of the investigator, the subject is not an appropriate candidate for the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer screening

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.